People

Megann Vaughn Watters

Megann Vaughn Watters leads Labcorp’s strategic corporate venture investing and new ventures and strategic alliances. Labcorp’s January 2026 Teal Health interview and AOA Dx’s January 2026 report identify her venture leadership; her 2026 Precision Med Tri-Conference speaker listing confirms Vice President, New Ventures and Strategic Alliances. Her published event biography describes experience identifying healthcare technologies, executing partnerships, equity investments and licensing, managing alliances and serving on venture-backed boards. Before Labcorp she was a U.S. Patent and Trademark Office medical-device patent examiner and conducted tissue-engineering research at Humacyte. She earned an MBA and a BSE in biomedical engineering at Duke University.